Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art

RSS



app icon

iPhone

app store icon

Kindle



Orthopedic and Dental Industry News

March 2005

Biomet (BMET:NASDAQ) Reports 3Q:05 Results; Knee Revenues Increase 31% BY JOHN CHOPACK, MARCH 28, 2005

Biomet reported an 18% increase in net sales which totaled $482 million during the 3Q:05. The company also reported earnings, excluding any one-time costs associated with its recent Interpore Cross or Biomet Merck acquisitions, totaled $0.40 per diluted share which... more

Synthes, Inc. (SYST:VX) Reported Sales and Net Earnings for FY2004 BY HUYEN NGUYEN, MARCH 28, 2005

As an addendum to the January 2005 financial sales release, on March 16/2005, Synthes provided the investment community with the group's sales and earnings financial reports for fiscal year 2004. Synthes reported on both a consolidated and pro forma basis.... more

ReGen Biologics (OTC:RGBI) Reports Selected Financials for FY2004 and a Brief CMI Update BY HUYEN NGUYEN, MARCH 21, 2005

ReGen Biologics, Inc. (OTC:RGBI), a New Jersey-based tissue regeneration company, reported full year 2004 selected financial results on Friday of last week. In 2004, ReGen reported total sales of $504,000, a 72% increase over the $293,000 reported in 2003. Net... more

Preservation of Motion in the Lumbar Spine: A Trip Report BY JOHN MCCORMICK, MARCH 21, 2005

At the end of last week, we attended the University of South Florida's "Preservation of Motion in the Lumbar Spine" course to check in on how leading surgeons are coming along with motion preserving spinal procedures and related surgical implant... more

What Price Innovation? | EDITORIAL | BY JOHN MCCORMICK, MARCH 21, 2005

I was struck by economist Paul Krugman's article "America's Senior Moment" in the most recent New York Review of Books. In the article Krugman assails the Bush Administration's push for social security "privatization" with the fervor of a campus radical,... more

ArthroCare (ARTC:NASDAQ) Beats Analyst Expectations in the 4Q:04 BY JOHN CHOPACK, MARCH 21, 2005

ARTC reported $42.7 million in net revenues during the 4Q:04 which was a 31% increase over the 4Q:03 and $600 thousand higher than analyst expectations. For 2004, revenues totaled $154.1 million compared to $118.9 million during 2003 which represents a... more

HealthpointCapital Announces Purchase of Alphatec Manufacturing, Inc. BY EDITOR, MARCH 18, 2005

HealthpointCapital Announces Purchase of Alphatec Manufacturing, Inc. Alphatec Manufacturing, Inc. is one of the largest independent spinal implant companies in the world. NEW YORK, New York, and CARLSBAD, California, March 18, 2005 /PRNewswire/ -- HealthpointCapital Partners, L.P. ("HealthpointCapital") announced today... more

LifeCell Corp. (NASDAQ:LIFC) Reported Strong Product Sales for 4Q:04 and FY:04 BY HUYEN NGUYEN, MARCH 14, 2005

LifeCell Corp. (NASDAQ:LIFC) reported a strong 49% increase in product revenues in 4Q:04 which was in line with consensus estimate of $0.04 per diluted share on a non-GAAP reporting standard. Product revenues in the 4Q:04 were $16 million compared to... more

4Q:04 Orthopedic Wrap-up BY JOHN CHOPACK, MARCH 14, 2005

We have aggregated the 4Q:04 and 3Q:04 reported revenues (includes the effects of foreign currency) for 16 public orthopedic companies. Although we would have liked to use revenue growth rates which excluded foreign currency, a majority of the companies report... more

Exactech (EXAC:NASDAQ) Reports 4Q:04 Financials which were slightly below Analyst Expectations BY JOHN CHOPACK, MARCH 7, 2005

EXAC reported revenues of $21.3 million during the 4Q:04 which was a 14% increase over the 4Q:03 but was $300 thousand below analyst's expectations. Earnings-per-share on a diluted basis totaled $0.17 which was also slightly below analyst expectations of $0.16.... more

Encore Medical (ENMC:NASDAQ) Reports 4Q:04 and 2004 Year-end Results BY JOHN CHOPACK, MARCH 7, 2005

From a business development and strategy execution standpoint/2004 was an excellent year for Encore. Management completed two acquisitions (Empi and Osteoimplant Technologies, Inc.) which fits the overall business development strategy of ENMC: growth via acquisition. The acquisitions helped drive revenues... more

Orthovita (NASDAQ:VITA) Reported 4Q:04 and FY2004 in which Product Sales Rose by 62% and 59%, Respectively BY HUYEN NGUYEN, MARCH 7, 2005

A biomaterial company, Orthovita, Inc. (Nasdaq: VITA), reported 4Q:04 and FY2004 financial results with product revenues increased to 62% and 59%, respectively. Despite its consistent 60% top-line growth in Q3 & Q4, VITA failed to meet the street estimate of... more

2005 AAOS: Louder, Yet Quieter than Ever Before BY JOHN CHOPACK, MARCH 1, 2005

The 2005 American Academy of Orthopaedic Surgeon Annual Conference was unique to recent meetings. It was louder in terms of the amount of marketing, size of exhibits and mass advertising, yet it was quieter in terms of business development and,... more

2005 AAOS Analyst Meeting Reviews BY JOHN CHOPACK, MARCH 1, 2005

This year we attended Smith & Nephew's, Biomet's, Stryker's, and Encore Medical's analyst meetings. All were very professional and well attended. Here are our notes from each: Smith & Nephew Overview: Although Smith & Nephew posted the best large joint... more


Complete Archive